DYADIC INTERNATIONAL INC (DYAI) Stock Price, Quote, News and Overview
NASDAQ:DYAI - Nasdaq - US26745T1016 - Common Stock - Currency: USD
DYAI Quote, Performance and Key Statistics
NASDAQ:DYAI (2/21/2025, 8:14:48 PM)
1.47
-0.03 (-2%)
The current stock price of DYAI is 1.47 USD. In the past month the price decreased by -4.55%. In the past year, price increased by 6.52%.
DYAI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About DYAI
Company Profile
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. The company is headquartered in Jupiter, Florida and currently employs 7 full-time employees. The company went IPO on 2004-11-05. The firm's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila). Its lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The firm has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.
Company Info
DYADIC INTERNATIONAL INC
1044 North U.S. Highway One, Suite 201
Jupiter FLORIDA 33477 US
CEO: Mark A. Emalfarb
Employees: 7
Company Website: https://dyadic.com/
Investor Relations: https://dyadic-international-inc.ir.rdgfilings.com/
Phone: 15617438333
DYADIC INTERNATIONAL INC / DYAI FAQ
What is the stock price of DYADIC INTERNATIONAL INC today?
The current stock price of DYAI is 1.47 USD. The price decreased by -2% in the last trading session.
What is the ticker symbol for DYADIC INTERNATIONAL INC stock?
The exchange symbol of DYADIC INTERNATIONAL INC is DYAI and it is listed on the Nasdaq exchange.
On which exchange is DYAI stock listed?
DYAI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for DYADIC INTERNATIONAL INC stock?
7 analysts have analysed DYAI and the average price target is 9.18 USD. This implies a price increase of 524.49% is expected in the next year compared to the current price of 1.47. Check the DYADIC INTERNATIONAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DYADIC INTERNATIONAL INC worth?
DYADIC INTERNATIONAL INC (DYAI) has a market capitalization of 43.50M USD. This makes DYAI a Nano Cap stock.
How many employees does DYADIC INTERNATIONAL INC have?
DYADIC INTERNATIONAL INC (DYAI) currently has 7 employees.
What are the support and resistance levels for DYADIC INTERNATIONAL INC (DYAI) stock?
DYADIC INTERNATIONAL INC (DYAI) has a support level at 1.46 and a resistance level at 1.63. Check the full technical report for a detailed analysis of DYAI support and resistance levels.
Is DYADIC INTERNATIONAL INC (DYAI) expected to grow?
The Revenue of DYADIC INTERNATIONAL INC (DYAI) is expected to grow by 40.98% in the next year. Check the estimates tab for more information on the DYAI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DYADIC INTERNATIONAL INC (DYAI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DYAI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DYAI, evaluating the profitability, health, valuation and growth aspects
- DYADIC INTERNATIONAL INC (DYAI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DYADIC INTERNATIONAL INC (DYAI) Sales and EPS estimates to see what analysts future expectations are.
- DYADIC INTERNATIONAL INC (DYAI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DYADIC INTERNATIONAL INC (DYAI) Insider and Institutional Ownership to learn about the owners and their transactions.
- DYADIC INTERNATIONAL INC (DYAI) Stock Chart to make your own analysis
- DYADIC INTERNATIONAL INC (DYAI) Latest news and press-releases to stay up to date.
Does DYADIC INTERNATIONAL INC (DYAI) stock pay dividends?
DYAI does not pay a dividend.
When does DYADIC INTERNATIONAL INC (DYAI) report earnings?
DYADIC INTERNATIONAL INC (DYAI) will report earnings on 2025-03-26, after the market close.
What is the Price/Earnings (PE) ratio of DYADIC INTERNATIONAL INC (DYAI)?
DYADIC INTERNATIONAL INC (DYAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.23).
What is the Short Interest ratio of DYADIC INTERNATIONAL INC (DYAI) stock?
The outstanding short interest for DYADIC INTERNATIONAL INC (DYAI) is 0.55% of its float. Check the ownership tab for more information on the DYAI short interest.
DYAI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to DYAI. When comparing the yearly performance of all stocks, DYAI is a bad performer in the overall market: 75.8% of all stocks are doing better.
DYAI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DYAI. DYAI has a bad profitability rating. Also its financial health evaluation is rather negative.
DYAI Financial Highlights
Over the last trailing twelve months DYAI reported a non-GAAP Earnings per Share(EPS) of -0.23. The EPS decreased by 0% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -58.58% | ||
| ROE | -185.52% | ||
| Debt/Equity | 1.54 |
DYAI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to DYAI. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 23.5% and a revenue growth 40.98% for DYAI